Document:

Exhibit
10.10

 

Suneva
Medical, Inc.

2022 Employee Stock Purchase Plan

 

Adopted
by the Board of Directors: [   ], 2022

Approved
by the Stockholders: [   ], 2022

 

1.
General; Purpose.

 

(a)
The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an opportunity
to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees under an
Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible Employees that
do not meet the requirements of an Employee Stock Purchase Plan.

 

(b)
The Plan includes two components: a Component and a Non-423 Component. The Company intends (but makes no undertaking or representation
to maintain) the 423 Component to qualify as an Employee Stock Purchase Plan. The provisions of the 423 Component, accordingly, will
be construed in a manner that is consistent with the requirements of Section 423 of the Code. Except as otherwise provided in the Plan
or determined by the Board, the Non-423 Component will operate and be administered in the same manner as the 423 Component.

 

(c)
The Company, by means of the Plan, seeks to retain the services of Eligible Employees, to secure and retain the services of new Employees
and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related Corporations.

 

2.
Administration.

 

(a)
The Board or the Committee will administer the Plan. References herein to the Board shall be deemed to refer to the Committee except
where context dictates otherwise.

 

(b)
The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:

 

(i)
To determine how and when Purchase Rights will be granted and the provisions of each Offering (which need not be identical).

 

(ii)
To designate from time to time (A) which Related Corporations will be eligible to participate in the Plan as Designated 423 Corporations,
(B) which Related Corporations or Affiliates will be eligible to participate in the Plan as Designated Non-423 Corporations, and (C)
which Designated Companies will participate in each separate Offering (to the extent that the Company makes separate Offerings).

 

(iii)
To impose one or more limitations (including holding periods) on the sale of shares purchased by Participants in an Offering.

 

(iv)
To construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules and regulations for its administration.
The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in a manner and to the extent
it deems necessary or expedient to make the Plan fully effective.

 

     

     

    

 

(v)
To settle all controversies regarding the Plan and Purchase Rights granted under the Plan.

 

(vi)
To suspend or terminate the Plan at any time as provided in Section 12.

 

(vii)
To amend the Plan at any time as provided in Section 12.

 

(viii)
Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to promote the best interests of the
Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase Plan with respect
to the 423 Component.

 

(ix)
To adopt such rules, procedures and sub-plans as are necessary or appropriate to permit or facilitate participation in the Plan by
Employees who are foreign nationals or employed or located outside the United States. Without limiting the generality of, and consistent
with, the foregoing, the Board specifically is authorized to adopt rules, procedures, and sub-plans regarding, without limitation, eligibility
to participate in the Plan, the definition of eligible “earnings,” handling and making of Contributions, establishment of
bank or trust accounts to hold Contributions, payment of interest, conversion of local currency, obligations to pay payroll tax, determination
of beneficiary designation requirements, withholding procedures and handling of share issuances, any of which may vary according to applicable
requirements, and which, if applicable to a Designated Non-423 Corporation, do not have to comply with the requirements of Section 423
of the Code.

 

(c)
The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration is delegated
to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board
that have been delegated to the Committee, including the power to delegate to a subcommittee any of the administrative powers the Committee
is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee), subject, however,
to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. Further, to
the extent not prohibited by Applicable Law, the Board or Committee may, from time to time, delegate some or all of its authority under
the Plan to one or more officers of the Company or other persons or groups of persons as it deems necessary, appropriate or advisable
under conditions or limitations that it may set at or after the time of the delegation. The Board may retain the authority to concurrently
administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. Whether
or not the Board has delegated administration of the Plan to a Committee, the Board will have the final power to determine all questions
of policy and expediency that may arise in the administration of the Plan.

 

(d)
All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person
and will be final, binding and conclusive on all persons.

 

3.
Shares of Common Stock Subject to the Plan.

 

(a)
Subject to the provisions of Section 11(a) relating to Capitalization Adjustments, the maximum number of shares of Common Stock that
may be issued under the Plan will not exceed [ ]1 shares of Common Stock, plus the number of shares of Common Stock that are
automatically added on January 1st of each year for a period of ten years commencing on January 1, 2023 and ending on (and
including) January 1, 2032, in an amount equal to the lesser of (i) [ ]% of the total number of shares of Common Stock outstanding on
December 31st of the preceding calendar year, and (ii) [ ] shares of Common Stock. Notwithstanding the foregoing, the Board
may act prior to the first day of any calendar year to provide that there will be no January 1st increase in the share reserve
for such calendar year or that the increase in the share reserve for such calendar year will be a lesser number of shares of Common Stock
than would otherwise occur pursuant to the preceding sentence. For the avoidance of doubt, up to the maximum number of shares of Common
Stock reserved under this Section 3(a) may be used to satisfy purchases of Common Stock under the 423 Component and any remaining portion
of such maximum number of shares may be used to satisfy purchases of Common Stock under the Non-423 Component.

 

 

	1	NTD:
                                            To be equal to 1% of shares of Common Stock outstanding immediately following the Effective
                                            Date.

 

    2

     

    

 

(b)
If any Purchase Right granted under the Plan terminates without having been exercised in full, the shares of Common Stock not purchased
under such Purchase Right will again become available for issuance under the Plan.

 

(c)
The stock purchasable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased
by the Company on the open market.

 

4.
Grant of Purchase Rights; Offering.

 

(a)
The Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under an Offering (consisting
of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering will be in such form and
will contain such terms and conditions as the Board will deem appropriate, and, with respect to the 423 Component, will comply with the
requirement of Section 423(b)(5) of the Code that all Employees granted Purchase Rights will have the same rights and privileges. The
terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as part of the Plan. The provisions
of separate Offerings need not be identical, but each Offering will include (through incorporation of the provisions of this Plan by
reference in the document comprising the Offering or otherwise) the period during which the Offering will be effective, which period
will not exceed 27 months beginning with the Offering Date, and the substance of the provisions contained in Sections 5 through 8, inclusive.

 

(b)
If a Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise indicates in forms delivered
to the Company or a third party designated by the Company (each, a “Company Designee”): (i) each form will
apply to all of his or her Purchase Rights under the Plan, and (ii) a Purchase Right with a lower exercise price (or an earlier-granted
Purchase Right, if different Purchase Rights have identical exercise prices) will be exercised to the fullest possible extent before
a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights have identical exercise
prices) will be exercised.

 

(c)
The Board will have the discretion to structure an Offering so that if the Fair Market Value of a share of Common Stock on the first
Trading Day of a new Purchase Period within that Offering is less than or equal to the Fair Market Value of a share of Common Stock on
the Offering Date for that Offering, then (i) that Offering will terminate immediately as of that first Trading Day, and (ii) the Participants
in such terminated Offering will be automatically enrolled in a new Offering beginning on the first Trading Day of such new Purchase
Period.

 

5.
Eligibility.

 

(a)
Purchase Rights may be granted only to Employees of the Company or, as the Board may designate in accordance with Section 2(b), to
Employees of a Related Corporation or an Affiliate. Except as provided in Section 5(b) or as required by Applicable Law, an Employee
will not be eligible to be granted Purchase Rights unless, on the Offering Date, the Employee has been in the employ of the Company,
the Related Corporation or an Affiliate, as the case may be, for such continuous period preceding such Offering Date as the Board may
require, but in no event will the required period of continuous employment be equal to or greater than two years. In addition, the Board
may (unless prohibited by Applicable Law) provide that no Employee will be eligible to be granted Purchase Rights under the Plan unless,
on the Offering Date, such Employee’s customary employment with the Company, the Related Corporation, or the Affiliate is more
than 20 hours per week and more than five months per calendar year or such other criteria as the Board may determine consistent with
Section 423 of the Code with respect to the 423 Component. The Board may also exclude from participation in the Plan or any Offering
Employees who are “highly compensated employees” (within the meaning of Section 423(b)(4)(D) of the Code) of the Company or
a Related Corporation or a subset of such highly compensated employees.

 

    3

     

    

 

(b)
The Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee will, on a date
or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or which occurs thereafter,
receive a Purchase Right under that Offering, which Purchase Right will thereafter be deemed to be a part of that Offering. Such Purchase
Right will have the same characteristics as any Purchase Rights originally granted under that Offering, as described herein, except that:

 

(i)
the date on which such Purchase Right is granted will be the “Offering Date” of such Purchase Right for all purposes,
including determination of the exercise price of such Purchase Right;

 

(ii)
the period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with the end of
such Offering; and

 

(iii)
the Board may provide that if such person first becomes an Eligible Employee within a specified period of time before the end of
the Offering, he or she will not receive any Purchase Right under that Offering.

 

(c)
No Employee will be eligible for the grant of any Purchase Rights under the 423 Component if, immediately after any such Purchase
Rights are granted, such Employee owns stock possessing five percent or more of the total combined voting power or value of all classes
of stock of the Company or of any Related Corporation. For purposes of this Section 5(c), the rules of Section 424(d) of the Code will
apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding Purchase Rights
and options will be treated as stock owned by such Employee.

 

(d)
As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights under the 423 Component only if
such Purchase Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations,
do not permit such Eligible Employee’s rights to purchase stock of the Company or any Related Corporation to accrue at a rate which,
when aggregated, exceeds US $25,000 of Fair Market Value of such stock (determined at the time such rights are granted, and which, with
respect to the Plan, will be determined as of their respective Offering Dates) for each calendar year in which such rights are outstanding
at any time.

 

(e)
Officers of the Company and any Designated Company, if they are otherwise Eligible Employees, will be eligible to participate in
Offerings under the Plan. Notwithstanding the foregoing, the Board may (unless prohibited by Applicable Law) provide in an Offering that
Employees who are highly compensated Employees within the meaning of Section 423(b)(4)(D) of the Code will not be eligible to participate.

 

(f)
Notwithstanding anything in this Section 5 to the contrary, in the case of an Offering under the Non-423 Component, an Eligible Employee
(or group of Eligible Employees) may be excluded from participation in the Plan or an Offering if the Board has determined, in its sole
discretion, that participation of such Eligible Employee(s) is not advisable or practical for any reason.

 

6.
Purchase Rights; Purchase Price.

 

(a)
On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a Purchase Right to purchase
up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount, as designated by the
Board (as defined by the Board in each Offering) during the period that begins on the Offering Date (or such later date as the Board
determines for a particular Offering) and ends on the date stated in the Offering, which date will be no later than the end of the Offering.

 

    4

     

    

 

(b)
The Board will establish one or more Purchase Dates during an Offering on which Purchase Rights granted for that Offering will be
exercised and shares of Common Stock will be purchased in accordance with such Offering.

 

(c)
In connection with each Offering made under the Plan, the Board may specify (i) a maximum number of shares of Common Stock that may
be purchased by any Participant on any Purchase Date during such Offering, (ii) a maximum aggregate number of shares of Common Stock
that may be purchased by all Participants pursuant to such Offering and/or (iii) a maximum aggregate number of shares of Common Stock
that may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate purchase of shares of Common Stock
issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate number, then, in the absence
of any Board action otherwise, a pro rata (based on each Participant’s accumulated Contributions) allocation of the shares of Common
Stock (rounded down to the nearest whole share) available will be made in as nearly a uniform manner as will be practicable and equitable.

 

(d)
The purchase price of shares of Common Stock acquired pursuant to Purchase Rights will be specified by Board prior to the commencement
of an Offering and will not be less than the lesser of:

 

(i)
an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the Offering Date; or

 

(ii)
an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the applicable Purchase Date.

 

7.
Participation; Withdrawal; Termination.

 

(a)
An Eligible Employee may elect to participate in an Offering and authorize payroll deductions as the means of making Contributions
by completing and delivering to the Company or a Company Designee, within the time specified for the Offering, an enrollment form provided
by the Company or Company Designee. The enrollment form will specify the amount of Contributions not to exceed the maximum amount specified
by the Board. Each Participant’s Contributions will be credited to a bookkeeping account for such Participant under the Plan and
will be deposited with the general funds of the Company except where Applicable Law requires that Contributions be deposited with a third
party. If permitted in the Offering, a Participant may begin such Contributions with the first payroll occurring on or after the Offering
Date (or, in the case of a payroll date that occurs after the end of the prior Offering but before the Offering Date of the next new
Offering, Contributions from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter
reduce (including to zero) or increase his or her Contributions. If required under Applicable Law or if specifically provided in the
Offering and to extent permitted by Section 423 of the Code with respect to the 423 Component, in addition to or instead of making Contributions
by payroll deductions, a Participant may make Contributions through payment by cash, check or wire transfer prior to a Purchase Date.

 

(b)
During an Offering, a Participant may cease making Contributions and withdraw from the Offering by delivering to the Company or a
Company Designee a withdrawal form provided by the Company. The Company may impose a deadline before a Purchase Date for withdrawing.
Upon such withdrawal, such Participant’s Purchase Right in that Offering will immediately terminate and the Company will distribute
as soon as practicable to such Participant all of his or her accumulated but unused Contributions and such Participant’s Purchase
Right in that Offering shall thereupon terminate. A Participant’s withdrawal from that Offering will have no effect upon his or
her eligibility to participate in any other Offerings under the Plan, but such Participant will be required to deliver a new enrollment
form to participate in subsequent Offerings.

 

    5

     

    

 

(c)
Unless otherwise required by Applicable Law, Purchase Rights granted pursuant to any Offering under the Plan will terminate immediately
if the Participant either (i) is no longer an Employee for any reason or for no reason (subject to any post-employment participation
period required by Applicable Law) or (ii) is otherwise no longer eligible to participate. The Company will distribute as soon as practicable
to such individual all of his or her accumulated but unused Contributions.

 

(d)
Unless otherwise determined by the Board, a Participant whose employment transfers or whose employment terminates with an immediate
rehire (with no break in service) by or between the Company and a Designated Company or between Designated Companies will not be treated
as having terminated employment for purposes of participating in the Plan or an Offering; however, if a Participant transfers from an
Offering under the 423 Component to an Offering under the Non-423 Component, the exercise of the Participant’s Purchase Right will
be qualified under the 423 Component only to the extent such exercise complies with Section 423 of the Code. If a Participant transfers
from an Offering under the Non-423 Component to an Offering under the 423 Component, the exercise of the Purchase Right will remain non-qualified
under the Non-423 Component. The Board may establish different and additional rules governing transfers between separate Offerings within
the 423 Component and between Offerings under the 423 Component and Offerings under the Non-423 Component.

 

(e)
During a Participant’s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase Rights are not transferable
by a Participant, except by will, by the laws of descent and distribution, or, if permitted by the Company, by a beneficiary designation
as described in Section 10.

 

(f)
Unless otherwise specified in the Offering or as required by Applicable Law, the Company will have no obligation to pay interest
on Contributions.

 

8.
Exercise of Purchase Rights.

 

(a)
On each Purchase Date, each Participant’s accumulated Contributions will be applied to the purchase of shares of Common Stock,
up to the maximum number of shares of Common Stock permitted by the Plan and the applicable Offering, at the purchase price specified
in the Offering. No fractional shares will be issued unless specifically provided for in the Offering.

 

(b)
Unless otherwise provided in the Offering, if any amount of accumulated Contributions remains in a Participant’s account after
the purchase of shares of Common Stock on the final Purchase Date of an Offering, then such remaining amount will not roll over to the
next Offering and will instead be distributed in full to such Participant after the final Purchase Date of such Offering without interest
(unless otherwise required by Applicable Law).

 

(c)
No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such exercise under the Plan
are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance with all applicable
U.S. federal and state, foreign and other securities, exchange control and other laws applicable to the Plan. If on a Purchase Date the
shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights will be exercised on such Purchase
Date, and, subject to Section 423 of the Code with respect to the 423 Component, the Purchase Date will be delayed until the shares of
Common Stock are subject to such an effective registration statement and the Plan is in material compliance, except that the Purchase
Date will in no event be more than 27 months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible,
the shares of Common Stock are not registered and the Plan is not in material compliance with all Applicable Laws, as determined by the
Company in its sole discretion, no Purchase Rights will be exercised and all accumulated but unused Contributions will be distributed
to the Participants without interest (unless the payment of interest is otherwise required by Applicable Law).

 

    6

     

    

 

9.
Covenants of the Company.

 

The
Company will seek to obtain from each U.S. federal or state, foreign or other regulatory commission, agency or other Governmental Body
having jurisdiction over the Plan such authority as may be required to grant Purchase Rights and issue and sell shares of Common Stock
thereunder unless the Company determines, in its sole discretion, that doing so is not practical or would cause the Company to incur
costs that are unreasonable. If, after commercially reasonable efforts, the Company is unable to obtain the authority that counsel for
the Company deems necessary for the grant of Purchase Rights or the lawful issuance and sale of Common Stock under the Plan, and at a
commercially reasonable cost, the Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and
sell Common Stock upon exercise of such Purchase Rights.

 

10.
Designation of Beneficiary.

 

(a)
The Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who will receive any shares
of Common Stock and/or Contributions from the Participant’s account under the Plan if the Participant dies before such shares and/or
Contributions are delivered to the Participant. The Company may, but is not obligated to, permit the Participant to change such designation
of beneficiary. Any such designation and/or change must be on a form approved by the Company.

 

(b)
 If a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any shares of Common Stock
and/or Contributions to the executor or administrator of the estate of the Participant. If no executor or administrator has been appointed
(to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock and/or Contributions,
without interest (unless the payment of interest is otherwise required by Applicable Law), to the Participant’s spouse, dependents
or relatives, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate.

 

11.
Adjustments upon Changes in Common Stock; Corporate Transactions.

 

(a)
In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum
number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities by which the share
reserve is to increase automatically each year pursuant to Section 3(a), (iii) the class(es) and number of securities subject to, and
the purchase price applicable to outstanding Offerings and Purchase Rights, and (iv) the class(es) and number of securities that are
the subject of the purchase limits under each ongoing Offering. The Board will make these adjustments, and its determination will be
final, binding and conclusive.

 

(b)
In the event of a Corporate Transaction, then: (i) any surviving corporation or acquiring corporation (or the surviving or acquiring
corporation’s parent company) may assume or continue outstanding Purchase Rights or may substitute similar rights (including a
right to acquire the same consideration paid to the stockholders in the Corporate Transaction) for outstanding Purchase Rights, or (ii)
if any surviving or acquiring corporation (or its parent company) does not assume or continue such Purchase Rights or does not substitute
similar rights for such Purchase Rights, then the Participants’ accumulated Contributions will be used to purchase shares of Common
Stock (rounded down to the nearest whole share) within ten business days (or such other period specified by the Board) prior to the Corporate
Transaction under the outstanding Purchase Rights, and the Purchase Rights will terminate immediately after such purchase.

 

    7

     

    

 

12.
Amendment, Termination or Suspension of the Plan.

 

(a)
The Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However, except as provided in Section
11(a) relating to Capitalization Adjustments, stockholder approval will be required for any amendment of the Plan for which stockholder
approval is required by Applicable Law.

 

(b)
The Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the Plan while the Plan is suspended
or after it is terminated.

 

Any
benefits, privileges, entitlements and obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination
of the Plan will not be materially impaired by any such amendment, suspension or termination except (i) with the consent of the person
to whom such Purchase Rights were granted, (ii) as necessary to facilitate compliance with any laws, listing requirements, or governmental
regulations (including, without limitation, the provisions of Section 423 of the Code and the regulations and other interpretive guidance
issued thereunder relating to Employee Stock Purchase Plans) including without limitation any such regulations or other guidance that
may be issued or amended after the date the Plan is adopted by the Board, or (iii) as necessary to obtain or maintain favorable tax,
listing, or regulatory treatment. To be clear, the Board may amend outstanding Purchase Rights without a Participant’s consent
if such amendment is necessary to ensure that the Purchase Right and/or the Plan complies with the requirements of Section 423 of the
Code with respect to the 423 Component or with respect to other Applicable Laws. Notwithstanding anything in the Plan or any Offering
Document to the contrary, the Board will be entitled to: (i) establish the exchange ratio applicable to amounts withheld in a currency
other than U.S. dollars; (ii) permit Contributions in excess of the amount designated by a Participant in order to adjust for mistakes
in the Company’s processing of properly completed Contribution elections; (iii) establish reasonable waiting and adjustment periods
and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly
correspond with amounts withheld from the Participant’s Contributions; (iv) amend any outstanding Purchase Rights or clarify any
ambiguities regarding the terms of any Offering to enable the Purchase Rights to qualify under and/or comply with Section 423 of
the Code with respect to the 423 Component; and (v) establish other limitations or procedures as the Board determines in its sole discretion
advisable that are consistent with the Plan. The actions of the Board pursuant to this paragraph will not be considered to alter or impair
any Purchase Rights granted under an Offering as they are part of the initial terms of each Offering and the Purchase Rights granted
under each Offering.

 

13.
Tax Qualification; Tax Withholding.

 

(a)
Although the Company may endeavor to (i) qualify a Purchase Right for special tax treatment under the laws of the United States or
jurisdictions outside of the United States or (ii) avoid adverse tax treatment, the Company makes no representation to that effect and
expressly disavows any covenant to maintain special or to avoid unfavorable tax treatment, notwithstanding anything to the contrary in
this Plan.  The Company will be unconstrained in its corporate activities without regard to the potential negative tax impact on
Participants.

 

(b)
Each Participant will make arrangements, satisfactory to the Company and any applicable Related Corporation, to enable the Company
or the Related Corporation to fulfill any withholding obligation for Tax-Related Items. Without limitation to the foregoing, in the Company’s
sole discretion and subject to Applicable Law, such withholding obligation may be satisfied in whole or in part by (i) withholding from
the Participant’s salary or any other cash payment due to the Participant from the Company or a Related Corporation; (ii) withholding
from the proceeds of the sale of shares of Common Stock acquired under the Plan, either through a voluntary sale or a mandatory sale
arranged by the Company; or (iii) any other method deemed acceptable by the Board. The Company shall not be required to issue any shares
of Common Stock under the Plan until such obligations are satisfied.

 

    8

     

    

 

(c)
The 423 Component is exempt from the application of Section 409A of the Code, and any ambiguities herein shall be interpreted to
so be exempt from Section 409A of the Code. The Non-423 Component is intended to be exempt from the application of Section 409A of the
Code under the short-term deferral exception and any ambiguities shall be construed and interpreted in accordance with such intent. In
furtherance of the foregoing and notwithstanding any provision in the Plan to the contrary, if the Committee determines that an option
granted under the Plan may be subject to Section 409A of the Code or that any provision in the Plan would cause an option under the Plan
to be subject to Section 409A, the Committee may amend the terms of the Plan and/or of an outstanding option granted under the Plan,
or take such other action the Committee determines is necessary or appropriate, in each case, without the participant’s consent,
to exempt any outstanding option or future option that may be granted under the Plan from or to allow any such options to comply with
Section 409A of the Code, but only to the extent any such amendments or action by the Committee would not violate Section 409A of the
Code. Notwithstanding the foregoing, the Company shall have no liability to a participant or any other party if the option under the
Plan that is intended to be exempt from or compliant with Section 409A of the Code is not so exempt or compliant or for any action taken
by the Committee with respect thereto.

 

14.
Effective Date of Plan.

 

The
Plan will become effective immediately prior to and contingent upon the Effective Date. No Purchase Rights will be exercised unless and
until the Plan has been approved by the stockholders of the Company, which approval must be within 12 months before or after the date
the Plan is adopted (or if required under Section 12(a) above, materially amended) by the Board.

 

15.
Miscellaneous Provisions.

 

(a)
Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights will constitute general funds of the Company.

 

(b)
A Participant will not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares of Common
Stock subject to Purchase Rights unless and until the Participant’s shares of Common Stock acquired upon exercise of Purchase Rights
are recorded in the books of the Company (or its transfer agent).

 

(c)
The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering will in any way alter the
at will nature of a Participant’s employment or amend a Participant’s employment contract, if applicable, or be deemed to
create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company or a Related Corporation
or an Affiliate, or on the part of the Company, a Related Corporation or an Affiliate to continue the employment of a Participant.

 

(d)
The provisions of the Plan will be governed by the laws of the State of Delaware without resort to that state’s conflicts of
laws rules.

 

(e)
If any particular provision of the Plan is found to be invalid or otherwise unenforceable, such provision will not affect the other
provisions of the Plan, but the Plan will be construed in all respects as if such invalid provision were omitted.

 

(f)
If any provision of the Plan does not comply with Applicable Law, such provision shall be construed in such a manner as to comply
with Applicable Law.

 

    9

     

    

 

16.
Definitions.

 

As
used in the Plan, the following definitions will apply to the capitalized terms indicated below:

 

(a)
“423 Component” means the part of the Plan, which excludes the Non-423 Component, pursuant to which Purchase
Rights that satisfy the requirements for an Employee Stock Purchase Plan may be granted to Eligible Employees.

 

(b)
“Affiliate” means any entity, other than a Related Corporation, whether now or subsequently established, which
is at the time of determination, a “parent” or “subsidiary” of the Company as such terms are defined in Rule
405 promulgated under the Securities Act. The Board may determine the time or times at which “parent” or “subsidiary”
status is determined within the foregoing definition.

 

(c)
“Applicable Law” means shall mean the Code and any applicable securities, federal, state, foreign, material
local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, listing
rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect
by or under the authority of any Governmental Body (or under the authority of the Nasdaq Stock Market, the New York Stock Exchange or
the Financial Industry Regulatory Authority).

 

(d)
“Board” means the board of directors of the Company.

 

(e)
“Capitalization Adjustment” means any change that is made in, or other events that occur with respect to,
the Common Stock subject to the Plan or subject to any Purchase Right after the date the Plan is adopted by the Board without the receipt
of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend
in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of shares, exchange of
shares, change in corporate structure or other similar equity restructuring transaction, as that term is used in Financial Accounting
Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion
of any convertible securities of the Company will not be treated as a Capitalization Adjustment.

 

(f)
 “Code” means the U.S. Internal Revenue Code of 1986, as amended, including any applicable regulations
and guidance thereunder.

 

(g)
“Committee” means a committee of one or more members of the Board to whom authority has been delegated
by the Board in accordance with Section 2(c).

 

(h)
“Common Stock” means the common stock of the Company.

 

(i)
 “Company” means Suneva Medical, Inc., a Delaware corporation.

 

(j)
“Contributions” means the payroll deductions and other additional payments specifically provided for in the Offering
that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional payments into his or her account
if specifically provided for in the Offering, and then only if the Participant has not already had the maximum permitted amount withheld
during the Offering through payroll deductions and, with respect to the 423 Component, to the extent permitted by Section 423 of the
Code.

 

    10

     

    

 

(k)
“Corporate Transaction” means the consummation, in a single transaction or in a series of related transactions,
of any one or more of the following events:

 

(i)
a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets
of the Company and its subsidiaries;

 

(ii)
a sale or other disposition of more than 50% of the outstanding securities of the Company;

 

(iii)
a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or

 

(iv)
a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the
merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

 

(l)
“Designated 423 Corporation” means any Related Corporation selected by the Board to participate in the 423 Component.

 

(m)
“Designated Company” means any Designated Non-423 Corporation or Designated 423 Corporation, provided, however,
that at any given time, a Related Corporation participating in the 423 Component shall not be a Related Corporation participating in
the Non-423 Component.

 

(n)
“Designated Non-423 Corporation” means any Related Corporation or Affiliate selected by the Board to participate
in the Non-423 Component.

 

(o)
“Director” means a member of the Board.

 

(p)
“Effective Date” means the effective date of this Plan, which is the date of the closing of the transactions
contemplated by the Merger Agreement by and among Viveon Health Acquisition Corp., [VHAC Merger Sub I, Inc.] and the Company, dated as
of [ ], 2022, provided that this Plan is approved by the Company’s stockholders prior to such date.

 

(q)
“Eligible Employee” means an Employee who meets the requirements set forth in the document(s) governing
the Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements for eligibility
to participate set forth in the Plan.

 

(r)
“Employee” means any person, including an Officer or Director, who is “employed” for purposes
of Section 423(b)(4) of the Code by the Company or a Related Corporation, or solely with respect to the Non-423 Component, an Affiliate.
However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an “Employee”
for purposes of the Plan.

 

(s)
“Employee Stock Purchase Plan” means a plan that grants Purchase Rights intended to be options issued under
an “employee stock purchase plan,” as that term is defined in Section 423(b) of the Code.

 

(t)
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended and the rules and regulations
promulgated thereunder.

 

    11

     

    

 

(u)
“Fair Market Value” means, as of any date, the value of the Common Stock determined as follows:

 

(i)
If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share
of Common Stock will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the
greatest volume of trading in the Common Stock) on the date of determination, as reported in such source as the Board deems reliable.
Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the
Fair Market Value will be the closing sales price on the last preceding date for which such quotation exists.

 

(ii)
In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith in compliance
with Applicable Laws and regulations and, to the extent applicable as determined in the sole discretion of the Board, in a manner that
complies with Sections 409A of the Code

 

(v)
 “Governmental Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality,
district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or
regulatory body, or quasi-governmental body of any nature (including any governmental division, department, administrative agency or
bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or entity and
any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising similar powers or authority;
or (d) self-regulatory organization (including the Nasdaq Stock Market, the New York Stock Exchange and the Financial Industry Regulatory
Authority).

 

(w)
“Non-423 Component” means the part of the Plan, which excludes the 423 Component, pursuant to which Purchase Rights
that are not intended to satisfy the requirements for an Employee Stock Purchase Plan may be granted to Eligible Employees.

 

(x)
“Offering” means the grant to Eligible Employees of Purchase Rights, with the exercise of those Purchase
Rights automatically occurring at the end of one or more Purchase Periods. The terms and conditions of an Offering will generally be
set forth in the “Offering Document” approved by the Board for that Offering.

 

(y)
“Offering Date” means a date selected by the Board for an Offering to commence.

 

(z)
“Officer” means a person who is an officer of the Company or a Related Corporation within the meaning of
Section 16 of the Exchange Act.

 

(aa)
“Participant” means an Eligible Employee who holds an outstanding Purchase Right.

 

(bb)
“Plan” means this Suneva Medical, Inc. 2022 Employee Stock Purchase Plan, as amended from time to time,
including both the 423 Component and the Non-423 Component.

 

    12

     

    

 

(cc)
“Purchase Date” means one or more dates during an Offering selected by the Board on which Purchase Rights
will be exercised and on which purchases of shares of Common Stock will be carried out in accordance with such Offering.

 

(dd)
“Purchase Period” means a period of time specified within an Offering, generally beginning on the Offering
Date or on the first Trading Day following a Purchase Date, and ending on a Purchase Date. An Offering may consist of one or more Purchase
Periods.

 

(ee)
“Purchase Right” means an option to purchase shares of Common Stock granted pursuant to the Plan.

 

(ff)
“Related Corporation” means any “parent corporation” or “subsidiary corporation”
of the Company whether now or subsequently established, as those terms are defined in Sections 424(e) and (f), respectively, of the Code.

 

(gg)
“Securities Act” means the U.S. Securities Act of 1933, as amended.

 

(hh)
“Tax-Related Items” means any income tax, social insurance, payroll tax, fringe benefit tax, payment on
account or other tax-related items arising out of or in relation to a Participant’s participation in the Plan, including, but not
limited to, the exercise of a Purchase Right and the receipt of shares of Common Stock or the sale or other disposition of shares of
Common Stock acquired under the Plan.

 

(ii)
“Trading Day” means any day on which the exchange(s) or market(s) on which shares of Common Stock are listed,
including but not limited to the New York Stock Exchange, Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market
or any successors thereto, is open for trading.

 

 

13Exhibit 10.1

EXECUTION VERSION
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
This First Amendment (“Amendment”) is dated as of the 3rd day of October, 2022 but is effective as of April 1, 2023 (“Amendment Effective Date”) by and between SouthState Bank, N.A. (the “Bank”) and Greg A. Lapointe (the “Executive”) (collectively, “the Parties”).
WHEREAS, the Bank and Executive are parties to that certain Employment Agreement, effective June 8, 2020 (“Agreement”); and
WHEREAS, the Bank and the Executive desire to amend the Agreement pursuant to Section 8.7 of the Agreement to among other things, transition the Executive to Senior Banking Advisor as of April 1, 2023 prior to Executive’s retirement date of December 31, 2023; 
NOW, THEREFORE, in consideration of the promises, the mutual covenants contained herein, and other good and valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
1.Defined Terms. All capitalized terms used but not defined herein shall have the meanings assigned to them in the Agreement. 
​
2.Amendments. The following provisions of the Agreement are hereby amended, modified, or supplemented as follows as of the Amendment Effective Date:
​
		a.	Section 1.1 (Employment) is amended by deleting the full section and replacing it with the following: 	

​
“Effective as of the Effective Time, the Bank shall employ the Executive to serve as the Chief Banking Officer of the Company and of the Bank, subject to the terms and conditions of this Agreement and during the Term (as defined in Section 1.2).  The Executive shall serve under the direction of the Chief Executive Officer of the Company and the Bank and shall have such duties and responsibilities as are consistent with the Executive’s position for a bank of similar size and complexity as the Bank.  The Executive shall exclusively devote full working time, energy, and attention to the business of the Company and the Bank and to the promotion of each entity’s interests throughout the Term.  Effective as of the Amendment Effective Date of April 1, 2023 and through the end of the Term (the “Transition Period”), the Executive shall transition from Chief Banking Officer to serve as the Senior Banking Advisor of the Company and of the Bank, subject to the terms and conditions of this Agreement.  During the Transition Period, the Executive shall devote at least twenty working hours per week to the business of the Company and the Bank and to the promotion of each entity’s interests.  The Executive shall serve the Company and the Bank faithfully, diligently, competently, and to the best of the Executive’s ability.  During the Term, without the prior written consent of the Company or the Bank, the Executive shall not render services to or for any person, firm, bank, or other entity or organization in exchange for compensation, regardless of the form in which the compensation is paid and regardless of whether it is paid directly or 

Page 1 of 3
​

indirectly to the Executive.  Nothing in this Section 1.1 shall prevent the Executive from managing his or her personal investments and affairs, or engaging in community and charitable activities, provided that doing so does not materially interfere with the proper performance of the Executive’s duties and responsibilities under this Agreement.”
		b.	Section 1.2 (Term) is amended by deleting the provision in its entirety and replacing it with the following sentence:  

​
“The term of employment shall be a period commencing upon the Effective Time and expiring on the close of business on December 31, 2023, subject to earlier termination or extension as provided herein (the “Term”).  At the conclusion of the Term, Executive’s employment shall terminate and have the impact set forth in Section 3.4 of the Agreement.”  
​
		c.	Section 2.2(a) (Incentive Compensation) is amended by adding the following sentence at the end thereof: 	

​
“During 2023, the Executive shall be entitled to receive the Executive’s cash incentive compensation that may be granted to Executive in 2022 in compliance with this Section and payable in 2023, and the full restricted stock units and performance share units granted in 2023 in compliance with this Section under the equity-based grant plan.” 
​
		d.	Section 3.3 (Involuntary Termination Without Cause and Voluntary Termination with Good Reason) is amended by adding the following sentence at the end thereof: 	

​
“Notwithstanding the foregoing, the change in the Executive’s title under the Amendment to Senior Banking Advisor shall not constitute “Good Reason” under this Section 3.3, causing a breach of the Agreement.” 
​
		e.	A new Section 4.4 to the Agreement is added as follows: 	

​
“4.4 End of Term Benefits.  Notwithstanding the other provisions of Article 4, but subject to Section 4.3, for the avoidance of doubt, at the end of the Term of the Agreement on December 31, 2023 subject to the Executive’s continued employment through that date, the Executive shall be entitled to the following benefits:  
​
		(a)	Effective January 1, 2024, Executive and Executive’s dependents and beneficiaries shall be eligible for eighteen (18) months medical and dental insurance coverage under COBRA substantially similar to that provided for the Executive as of the date of termination at Executive’s expense;  	

​
		(b)	Subject to the Executive’s compliance with the 24-month noncompete and nonsolicitation provisions set forth in Article 7 of the Agreement, Executive shall be eligible for the continued vesting of the then-outstanding Restricted Stock Units granted to Executive pursuant to 	

Page 2 of 3
​

			Section 3.3(a) of each applicable Restricted Stock Unit Agreement entered into by Executive; and the continued vesting and treatment of then outstanding vested Performance Stock Units, including accrual and payment of dividend equivalents during the vesting period, set forth in Section 5.3(a) of each applicable Performance Stock Unit Agreement entered into by Executive until each such RSUs and PSUs are fully vested;	

​
		(c)	Vested but unexercised stock options granted to Executive shall be eligible for exercise for a period of five (5) years after Executive’s retirement date of December 31, 2023; and 	

​
		(d)	Executive shall be allowed to retain his cell phone and cell phone number.”	

​
		f.	Section 7.1(f) is amended by deleting the definition of “Restricted Period”  therein and replacing it with the following provision: 	

​
“Restricted Period” means (i) the Term and (ii) the 24-month period commencing as of the end of the Term of this Agreement (i.e., December 31, 2023) and continuing until the end of such 24 month period (i.e., December 31, 2025).”   
​
3.Conflicts. In the event of a conflict or inconsistency between this Amendment and the Agreement, this Amendment shall control.
​
4.Full Force and Effect. All terms of the Agreement not amended by this Amendment shall remain in full force and effect. 
​
IN WITNESS WHEREOF, the undersigned have entered into this Amendment as of the date set forth above. 
	​
	​

	SOUTHSTATE BANK, NATIONAL ASSOCIATION

	

	​

	

​

Page 3 of 3
​

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]